DEA Revokes Doctor's Controlled Substance License

You might care about this because the Drug Enforcement Administration, also known as the DEA, has taken a firm stand on a doctor's ability to prescribe controlled medicines. This document explains why Dr. Frederick Tanzer's DEA registration was revoked. The DEA started this process by sending him an "Order to Show Cause" in late 2025. This order suggested that his registration should be taken away because he was no longer allowed to handle controlled substances in Ohio. Dr. Tanzer, who is from Cincinnati, Ohio, did not respond to this order by asking for a hearing. Because he did not respond, the law says he basically agreed to the facts presented by the DEA. The main fact was that his Ohio medical license had been permanently revoked by the Ohio Medical Board back in March 2025. This meant he could no longer legally practice medicine in Ohio. Since a DEA registration depends on having an active state medical license to prescribe controlled substances, the DEA decided that Dr. Tanzer was no longer eligible. Therefore, the DEA issued a formal order to revoke his DEA registration. They also denied any other applications he might have had to renew or change his registration in Ohio. This decision shows how closely the DEA links a doctor's federal registration to their state medical license. This decision is particularly interesting because it clearly shows how important a state medical license is for doctors who want to prescribe controlled medicines. The DEA's rule is that if a doctor loses their state license to practice medicine, they also lose their federal authority to prescribe controlled substances. This document highlights that connection very directly. It also illustrates the process the DEA follows when a doctor does not respond to a formal notice. Dr. Tanzer's failure to request a hearing meant the DEA could move forward based on his default, effectively accepting the allegations against him. This case reinforces a long-standing legal principle that to hold a DEA registration, a practitioner must have current state authority. It confirms that the DEA will act swiftly to remove federal prescribing privileges when a state medical board takes action against a doctor's license. This makes sure that only doctors who are fully authorized by their state can handle controlled substances, protecting public safety. Doctors, especially those who prescribe controlled substances, would find this document very relevant. It serves as a reminder that their DEA registration is directly tied to maintaining an active and unrestricted state medical license. Pharmacists and other healthcare providers who dispense controlled substances might also be interested, as it clarifies the legal framework that governs who can legitimately prescribe these medicines. Legal professionals who advise healthcare providers or who work with medical licensing issues would find the legal arguments and citations helpful. State medical boards could use this as an example of how their actions directly affect a doctor's federal prescribing authority. Finally, patients and the general public might be interested in understanding the systems in place to ensure that controlled substances are only prescribed by authorized and properly licensed medical professionals, contributing to public health and safety.